Co-delivery of sorafenib and an FSP1 inhibitor triggers dual ferroptosis in tumor cells and immunosuppressive macrophages for enhanced immunotherapy in mouse models of hepatocellular carcinoma

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-65056-9
Affiliations:
9
Authors:
13
Go to article
Institutions Authors Share
Zhujiang Hospital of Southern Medical University, China
4.666667
 0.36
Guangdong Provincial Clinical and Engineering Center of Digital Medicine at Zhujiang Hospital, SMU, China
1.833333
 0.14
Sir Run Run Shaw Hospital (SRRSH), Zhejiang University School of Medicine, China
1.833333
 0.14
Shenzhen Institutes of Advanced Technology (SIAT), CAS, China
1.833333
 0.14
State Key Laboratory of Biomedical Imaging Science and System, SIAT CAS, China
1.833333
 0.14
Guangdong Second Provincial General Hospital, China
0.500000
 0.04
Jinan University (JNU), China
0.500000
 0.04
Interested in Oncology and Carcinogenesis?